MTNB: Matinas BioPharma Holdings, Inc. Stock

by  •  • Comments Off on MTNB: Matinas BioPharma Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 47.66
Enterprise Value ($M) 42.87
Book Value ($M) 19.25
Book Value / Share 0.08
Price / Book 2.48
NCAV ($M) 9.69
NCAV / Share 0.04
Price / NCAV 4.92

Profitability (mra)
Return on Invested Capital (ROIC) -1.01
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.70

Liquidity (mrq)
Quick Ratio 5.93
Current Ratio 5.93

Balance Sheet (mrq) ($M)
Current Assets 15.54
Assets 25.10
Liabilities 5.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.10
Operating Income -23.77
Net Income -22.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -15.28
Cash from Investing 13.24
Cash from Financing -0.01

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACTOF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTIO
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 50,443 323,453 15.60
2024-04-18 312,920 937,803 33.37
2024-04-17 201,724 1,010,607 19.96
2024-04-16 136,943 778,739 17.59
2024-04-15 98,405 834,760 11.79

(click for more detail)

Similar Companies
IGC – IGC Pharma, Inc. LCTX – Lineage Cell Therapeutics, Inc.
MAIA – MAIA Biotechnology, Inc. NBY – NovaBay Pharmaceuticals, Inc.
NNVC – NanoViricides, Inc.


Financial data and stock pages provided by
Fintel.io